Clinical Trials Directory

Trials / Completed

CompletedNCT00912197

Effect of Oligofructose on Appetite in Overweight Subjects

Effect of Oligofructose on Appetite, Gut Hormones and Body Composition in Healthy Overweight Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study seeks to look into the effects of oligofructose supplementation on appetite, energy intake, and body weight and body composition in overweight subjects. Compared to a placebo product (cellulose) oligofructose is hypothesised to suppress hunger and thereby reduce food intake moderately leading to a decrease in body weight.

Detailed description

Appetite regulation plays an important part in energy balance. Suppressing appetite by manipulating the diet is a safe way of reducing energy intake and body weight compared to drug therapy and obesity surgery. How various nutrients affect appetite is not fully understood. Non-digestible carbohydrates (NDC) may affect appetite differently due to differences in physio-chemical properties. This project will look into how two different NDC affect appetite and energy intake in overweight individuals in a randomised, double-blinded, placebo controlled parallel study. The NDC under investigation are oligofructose and cellulose, both natural compounds of plant origin. The former is broken down (fermented) in the large bowel by friendly bacteria producing various compounds that may affect appetite and the metabolism of the host. Volunteers will consume one of the two NDC for eight weeks (including a two week run-in period). Appetite study session, functional MRI (fMRI) and MRI body fat scans will be conducted before and after the supplementation with NDC (or during the supplementation in the case of fMRI). Using fMRI the effect of the NDC supplementation on central appetite regulating centres will be investigated. Appetite questionnaires and dietary records will completed under free-living conditions at baseline and during the supplementation to explore the effect on subjective appetite feelings and energy intake, respectively. It is hoped that this project will enhance the understanding of how NDC affect appetite and provide further information on how fermentation of NDC, gut hormone release, body composition, and appetite regulation are linked.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOligofructoseParticipants will be asked to consume 30g of oligofructose daily for six weeks after a 2-week run-in.
DIETARY_SUPPLEMENTPlaceboParticipants will be asked to consume 3 doses (a total of 30g dietary fibres) of the placebo product daily for six weeks after a 2-week run-in

Timeline

Start date
2009-06-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2009-06-03
Last updated
2021-01-14
Results posted
2020-12-30

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00912197. Inclusion in this directory is not an endorsement.